Article
Multiple pathways of recombination define cellular responses to cisplatin.
Chemistry & biology - 1 Jan 2000
Zdraveski Z Z, Mello J A, Marinus M G, Essigmann J M
Abstract excerpt
BACKGROUND: Cisplatin is a DNA-damaging drug used for treatment of testicular tumors. The toxicity of cisplatin probably results from its ability to form DNA adducts that inhibit polymerases. Blocked replication represents a particular challenge for tumor cells, which are committed to unremitting division. Recombination provides a mechanism by which replication can proceed despite the presence of lesions and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
